News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
53,320 Results
Type
Article (4746)
Company Profile (14)
Press Release (48560)
Section
Business (16973)
Career Advice (248)
Deals (2639)
Drug Delivery (5)
Drug Development (2850)
Employer Resources (23)
FDA (1096)
Job Trends (1666)
News (23908)
Policy (2106)
Tag
Academia (556)
Africa (106)
Alliances (5678)
Alzheimer's disease (103)
Approvals (1093)
Arizona (13)
Artificial intelligence (15)
Asia (2983)
Australia (400)
Bankruptcy (23)
Best Places to Work (1155)
C2C Services and Suppliers (7489)
California (160)
Canada (78)
Cancer (39)
Career advice (215)
Career pathing (6)
Cell therapy (11)
China (7)
Clinical research (1776)
Collaboration (19)
Colorado (8)
Connecticut (12)
COVID-19 (416)
Cystic fibrosis (6)
Data (25)
Diagnostics (1653)
Earnings (4221)
Employer resources (21)
Europe (5924)
Events (5549)
Executive appointments (16)
FDA (1116)
Florida (13)
Funding (16)
Gene therapy (7)
Georgia (15)
GLP-1 (46)
Government (460)
Healthcare (1513)
Hotbed/Location (35931)
Illinois (24)
Indiana (19)
Infectious disease (419)
Inflammatory bowel disease (9)
Interviews (32)
IPO (890)
Job creations (512)
Job search strategy (196)
Layoffs (33)
Legal (345)
Lung cancer (9)
Manufacturing (19)
Maryland (22)
Massachusetts (125)
Medical device (955)
Medtech (955)
Mergers & acquisitions (1748)
Metabolic disorders (13)
Michigan (42)
Minnesota (17)
Neuroscience (111)
New Jersey (41)
New Mexico (8)
New York (43)
NextGen Class of 2024 (710)
Non-profit (541)
North Carolina (59)
Northern California (74)
Now hiring (11)
Obesity (10)
Ohio (17)
Opinion (32)
Pennsylvania (53)
People (4606)
Phase I (650)
Phase II (800)
Phase III (637)
Pipeline (14)
Postmarket research (91)
Preclinical (476)
Press Release (18)
Radiopharmaceuticals (10)
Rare diseases (9)
Real estate (1416)
Recruiting (13)
Regulatory (1385)
Reports (10)
Research institute (519)
Resumes & cover letters (29)
South America (190)
Southern California (59)
Sponsored (6)
Startups (484)
Texas (16)
United States (777)
Utah (12)
Vaccines (22)
Washington State (16)
Weight loss (6)
Date
Last 7 days (66)
Last 30 days (193)
Last 365 days (2913)
2024 (2192)
2023 (3283)
2022 (4739)
2021 (4994)
2020 (5648)
2019 (4212)
2018 (3014)
2017 (2947)
2016 (3144)
2015 (3163)
2014 (2184)
2013 (1940)
2012 (2074)
2011 (2186)
2010 (1618)
53,320 Results for "prophase labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Business
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its financial and operational results for the three months ended March 31, 2024.
May 9, 2024
·
24 min read
Business
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
ProPhase Labs, Inc. today reported that Jason Karkus, one of the driving forces behind ProPhase Diagnostics, becomes President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs.
January 30, 2024
·
5 min read
Pharm Country
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
ProPhase Labs, Inc. today reported its progress on the commercialization of its breakthrough BE-Smart test for esophageal cancer.
April 10, 2024
·
7 min read
Pharm Country
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
ProPhase Labs, Inc. today announced positive preliminary results from its Equivir dietary supplement comprehensive trial.
February 14, 2024
·
5 min read
Pharm Country
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated
ProPhase Labs, Inc., a next-generation biotech, genomics, and diagnostics company, reported its financial and operational results for the three months ended March 31, 2024.
May 9, 2024
·
24 min read
Press Releases
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
August 19, 2024
·
1 min read
Business
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call hosted by Renmark Financial on March 15, 2024 at 11:00 am EDT.
March 8, 2024
·
1 min read
Business
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
ProPhase Labs, Inc. today reported its financial and operational results for the full-year ended December 31, 2023.
March 15, 2024
·
26 min read
Press Releases
PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14
August 7, 2024
·
1 min read
1 of 5,332
Next
